학술논문
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
Document Type
Article
Author
Felip, Enriqueta ; Altorki, Nasser; Zhou, Caicun; Csőszi, Tibor; Vynnychenko, Ihor; Goloborodko, Oleksandr; Luft, Alexander; Akopov, Andrey; Martinez-Marti, Alex; Kenmotsu, Hirotsugu; Chen, Yuh-Min; Chella, Antonio; Sugawara, Shunichi; Voong, David; Wu, Fan; Yi, Jing; Deng, Yu; McCleland, Mark; Bennett, Elizabeth; Gitlitz, Barbara; Wakelee, Heather
Source
In The Lancet 9-15 October 2021 398(10308):1344-1357
Subject
Language
ISSN
0140-6736